Back
aTyr Pharma, Inc. 10K Form
Sell
45
ATYR
aTyr Pharma, Inc.
Last Price:
$0.74
Seasonality Move:
-2.14%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ATYR News And Ratings
See the #1 stock for the next 7 days that we like better than ATYR
ATYR Financial Statistics
Sales & Book Value
| Annual Sales: | $235K |
|---|---|
| Cash Flow: | $-20.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.82 |
| Price / Book: | 0.9 |
Profitability
| EPS (TTM): | -0.83460 |
|---|---|
| Net Income (TTM): | $-75.1M |
| Gross Margin: | $-1.3M |
| Return on Equity: | -103.05% |
| Return on Assets: | -75.87% |
aTyr Pharma, Inc. Earnings Forecast
Key aTyr Pharma, Inc. Financial Ratios
-
The Gross Profit Margin over the past 13 years for ATYR is -555.32%.
-
The Selling, General & Administrative Expenses for ATYR have been equal to 5,862.55% of Gross Profit Margin.
-
The Research & Development expenses have been 23,137.02% of Revenue.
-
The Net Earning history of ATYR is -27,243.40% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 10 years.
aTyr Pharma, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ATYR |
| Website: | atyrpharma.com |
Debt
| Debt-to-Equity Ratio: | 0.15 |
|---|---|
| Current Ratio: | 5.93 |
| Quick Ratio: | 5.75 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ATYR Technical Analysis vs Fundamental Analysis
Sell
45
aTyr Pharma, Inc. (ATYR)
is a Sell
Is aTyr Pharma, Inc. a Buy or a Sell?
-
aTyr Pharma, Inc. stock is rated a SellThe current aTyr Pharma, Inc. [ATYR] share price is $0.74. The Score for ATYR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.